Thyrocare Technologies will increase the number of processing centres by 25 in next 36-48 months. This step will help to boost volume growth and expand its regional presence. It also aims to maintain the revenue growth of 30 percent in FY17.
The company’s topline grew by 32 percent to Rs 241 crore in fiscal year 2016. Its operating margin was around 40.2 percent and profit after tax saw a jump of 15 percent to Rs 51.80 crore in FY16.
Thyrocare Technologies is one of the leading pan-India diagnostic chains and conducts an array of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases.
